or Try an Advanced Search...

    Technical Analysis for ICCM - IceCure Medical Ltd.

    Grade Last Price % Change Price Change
    C 0.81 -1.10% -0.01
    ICCM closed down 1.1 percent on Friday, November 1, 2024, on 66 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical ICCM trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Calm After Storm Range Contraction -1.10%
    Wide Range Bar Range Expansion -1.10%
    Upper Bollinger Band Walk Strength -1.10%
    Wide Bands Range Expansion -1.10%
    Older End-of-Day Signals for ICCM ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 21 hours ago
    Up 3% about 21 hours ago
    Down 2 % about 21 hours ago
    Down 1% about 21 hours ago
    Up 2% about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ICCM Chart by TradingView
    Basic chart:

    Profile

    Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.
    Classification
    Sector: Healthcare
    Industry: Medical Care Facilities
    Keywords: Medicine Clinical Medicine Tumor Breast Cancer FDA Interventional Radiology Lung Cancer Cryoablation Interventional Oncology

    Is ICCM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 29 Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders
    Oct 21 IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System
    Oct 15 IceCure Medical files to sell ordinary shares and warrants
    Oct 10 Alignment HealthCare Partners With Intermountain Health in Nevada
    Oct 7 IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference
    Oct 3 Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic
    Sep 24 IceCure's ICE3 5-Year Trial Results Published in the Peer Reviewed Annals of Surgical Oncology Journal: ProSense® Cryoablation Without Excision for Early-Stage, Low-Risk Breast Cancer Demonstrates 96.3% Recurrence Free Rate
    Sep 16 Study Published in the British Journal of Radiology Demonstrates IceCure's ProSense® is a Safe Procedure with 97.7% Technical Success Rate in Treating Tumors of the Lung, Bone, and Soft Tissues
    Sep 12 FDA AdComm to discuss IceCure's ProSense on Nov. 7
    Sep 12 IceCure Announces FDA Advisory Panel Meeting Date for Marketing Authorization of ProSense® in Early-Stage Low Risk Breast Cancer Scheduled for November 7, 2024
    See more ICCM news...

    Comments

    S

    SociableGnat503 about 1 year ago

    Is anyone here following this one? 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.57
    52 Week Low 0.48
    Average Volume 459,163
    200-Day Moving Average 0.94
    50-Day Moving Average 0.63
    20-Day Moving Average 0.62
    10-Day Moving Average 0.68
    Average True Range 0.07
    RSI (14) 72.38
    ADX 26.45
    +DI 35.27
    -DI 18.01
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.68
    Upper Bollinger Bands 0.82
    Lower Bollinger Band 0.42
    Percent B (%b) 0.97
    BandWidth 64.48
    MACD Line 0.05
    MACD Signal Line 0.01
    MACD Histogram 0.0332
    Fundamentals Value
    Market Cap 37.09 Million
    Num Shares 45.7 Million
    EPS -0.36
    Price-to-Earnings (P/E) Ratio -2.25
    Price-to-Sales 22.29
    Price-to-Book 4.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.92
    Resistance 3 (R3) 0.92 0.88 0.90
    Resistance 2 (R2) 0.88 0.86 0.88 0.89
    Resistance 1 (R1) 0.85 0.84 0.83 0.85 0.89
    Pivot Point 0.81 0.81 0.81 0.81 0.81
    Support 1 (S1) 0.78 0.79 0.76 0.78 0.74
    Support 2 (S2) 0.74 0.77 0.74 0.73
    Support 3 (S3) 0.71 0.74 0.72
    Support 4 (S4) 0.71